Clinical Trials Sponsored by MediGene
Total 13256 results
-
MediGeneCompletedBreast NeoplasmsBelgium, France, Poland, India, Romania, Ukraine
-
MediGeneCompletedNeoplasm Metastasis | Liver CancerGermany
-
MediGeneCompletedLiver Neoplasms | Colorectal CancerUnited States
-
MediGeneCompletedFormulation FindingUnited Kingdom
-
MediGeneCompleted
-
MediGeneTerminatedPharmacokineticsUnited Kingdom
-
MediGeneCompletedAdenocarcinoma | Metastasis | Pancreas NeoplasmsUkraine, Czech Republic, Hungary
-
MediGeneCompleted
-
MediGeneCompletedCondylomata AcuminataUnited States, Argentina, Chile, Colombia, Mexico, Peru, Romania
-
MediGeneCompletedGlioma | Glioblastoma | Astrocytoma
-
Medigene AGTerminatedFeasibility | Tolerability | Safety | Treatment EfficacyGermany
-
Medigene AGCompleted
-
Medigene AGWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Myelofibrosis | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia | Malignant LymphomaNetherlands
-
MediGeneNational Cancer Institute (NCI)Completed
-
MediGeneCharité Research Organisation GmbHCompletedGenital Warts | Perianal WartsGermany
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
BeiGeneRecruitingMelanoma | Renal Cell Carcinoma | Urothelial CarcinomaChina
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneRecruitingSolid Tumor, AdultUnited States, Australia, New Zealand, China, Korea, Republic of
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell MalignancyUnited States, Spain, Italy, Australia, France, Korea, Republic of, Canada, Georgia, Sweden, Germany, Moldova, Republic of
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
BeiGeneActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)China
-
BeiGeneActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)United States, China, Spain, Australia, Czechia, Japan, Belgium, Korea, Republic of, Italy, Germany, France, Romania, Poland, United Kingdom, Russian Federation, Taiwan
-
BeiGeneCompletedEsophageal Squamous Cell CarcinomaKorea, Republic of, Spain, China, Thailand, Taiwan, France
-
BeiGeneCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaPoland
-
BeiGeneTerminatedEsophageal Squamous Cell CarcinomaChina
-
BeiGeneCompletedA Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung CancerNon-Small Cell Lung CancerChina
-
BeiGeneCompletedHepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
BeiGeneActive, not recruitingMature B-cell MalignanciesJapan
-
BeiGeneCompletedNon-small Cell Lung CancerChina, Russian Federation, New Zealand, Lithuania, Turkey, Brazil, Bulgaria, Poland, Mexico, Slovakia
-
BeiGeneActive, not recruitingNon Small Cell Lung CancerChina
-
BeiGeneActive, not recruitingMature B-cell MalignanciesChina
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
BeiGeneActive, not recruitingMantle Cell Lymphoma; Non-Hodgkin LymphomaJapan
-
BeiGeneCompletedHepatocellular Carcinoma (HCC)China, Italy, United States, Germany, Japan, Taiwan, Czechia, Spain, United Kingdom, France, Poland
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
BeiGeneCompletedLimited Stage Small Cell Lung CancerChina, Korea, Republic of, United States
-
BeiGeneCompletedHepatocellular Carcinoma (HCC)Spain, China, Taiwan, Germany, Italy, United Kingdom, France, Poland
-
BeiGeneCompletedWaldenström's MacroglobulinemiaUnited States, Spain, Australia, France, United Kingdom, Germany, Netherlands, Czechia, Italy, Poland, Belgium, Greece, Sweden
-
BeiGeneCompletedNon-Small Cell Lung CancerChina
-
BeiGeneCompletedCarcinoma, Hepatocellular | Gastric/Gastroesophageal Junction CancerChina
-
BeiGeneCompletedAdvanced Solid TumorsChina, Australia
-
BeiGeneWithdrawnHealthy VolunteersUnited States
-
BeiGeneCompletedCOVID-19 | COVID-19 Pulmonary ComplicationsUnited States